"Having a safe and effective vaccine available for children in this age group is a priority," acting FDA Commissioner Janet Woodcock said. The move could speed up the inoculation timeline for this age group by months. In 6- month- to 24-month-old children, the vaccine generated an immune response in line with 16- to 25-year-olds. The vaccine is already approved for emergency use in children in the United States as young as 5. It gave the green light for a two-dose vaccine for children ages 5 to 11.

Source: The Star February 02, 2022 03:16 UTC